Nirav Dhanesha and LSU Health Shreveport Team Discover Neutrophil Integrin α9 as a Key Target in Subarachnoid Hemorrhage Recovery
Nirav Dhanesha, Assistant Professor at the Louisiana State University, shared an important post on LinkedIn:
“Excited to share our latest research on subarachnoid hemorrhage SAH! Our study in Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) reveals a novel role for neutrophil integrin α9 ITGA9 in sensorimotor and cognitive recovery after SAH.
We found that targeting ITGA9, which is expressed on neutrophils, significantly reduces inflammation and neuronal apoptosis. This leads to improved long-term outcomes after SAH.
Huge congratulations to the first author, Harpreet Kaur, Ph.D. for her outstanding work and dedication to this project! Her dedication was instrumental in the success of this study.
Special thanks to all the co-authors Arif Yurdagul Oren Rom, PhD, RD Wayne Orr Mohammad Alfrad Nobel Bhuiyan, PhD Rajesh Mohandas Ajit Vikram Kevin Murnane Xiao-Hong Lu for their invaluable support and collaborative spirit. This was a true team effort! LSU Health Shreveport”
Read the article here:
Article: Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid Hemorrhage
Authors: Harpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, Nirvana Shaaban, Dhananjay Kumar, Rajan Pandit, Alexa Martinez, Sumit Kumar Anand, Sandeep Das, Sumati Rohilla, Fabio Arias, Erika Reece, Ravinder Reddy Gaddam, Kevin S. Murnane, Ajit Vikram, Rajesh Mohandas, Xiaolu Zhang, Mohammad Alfrad Nobel Bhuiyan, Xiao-Hong Lu, A. Wayne Orr, Oren Rom, Arif Yurdagul Jr, Nirav Dhanesha
Follow the latest insights in hematology with Hemostasis Today.
-
Oct 19, 2025, 04:29Peter Mezes Thanks Thrombosis UK and North Bristol NHS Trust for The Support
-
Oct 19, 2025, 04:02Salvador Payán Pernía Highlights PIGA Gene Case and Thalassemia Advances at 5th Rare Diseases Conference in Hematology
-
Oct 18, 2025, 16:59Raul Santos Gave 2 Talks at SAC 2025: On The Role of LDL-C and Future of Lipid-lowering Therapies
-
Oct 18, 2025, 16:57Marilena Vrana: What An Inspiring Week at The 2025 Plasma Protein Forum and Business Forum
-
Oct 18, 2025, 16:53Caitlin Raymond: When Technology Meets Physiology in Neonatal Patients
-
Oct 19, 2025, 04:59Nazim Arain Shares The New Standard: Anticoagulation in Cirrhosis
-
Oct 19, 2025, 04:43Andrea Zini on Atrial Fibrillation Detection After Acute Ischemic Stroke
-
Oct 19, 2025, 03:43Ibrahim Antoun Describes LV Thrombus of Unknown Origin in Apical HCM
-
Oct 18, 2025, 16:56Alexandra Whiteside on Improving Coagulation Kinetics
-
Oct 18, 2025, 16:52Wolfgang Miesbach on Differential Diagnosis of Thrombocytopenia
-
Oct 16, 2025, 06:07ClearPlasma - A New Breakthrough in Stopping Life-Threatening Bleeds
-
Oct 14, 2025, 05:26Ryan C. Heniford: Every Thrombus Prevented Is a Patient Protected
-
Oct 13, 2025, 04:48Archil Jaliashvili showcases how BHOC builds on Hemopure’s success to revolutionize surgery and care
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 19, 2025, 04:14Sue Bacon: Ensure That You and Your Loved Ones Are Aware of The Signs and Symptoms of DVT And PE
-
Oct 19, 2025, 03:52Yazan Abou Ismail Receives The Qatar Foundation Legacy Award
-
Oct 18, 2025, 16:55Emilia Arturo: Your Reminder to Donate Blood If You Can, When You Can
-
Oct 18, 2025, 16:51Allison Wheeler Rallies Support for Magdalena Lewandowska's NYC Marathon Run Benefiting NBDF
-
Oct 18, 2025, 05:19Shashi Prakash: Test Your Clotting Concepts!